发明公开
EP1848806A1 ANTI-T CELL AND AUTOANTIGEN TREATMENT OF AUTOIMMUNE DISEASE
审中-公开
ANTI-T细胞和自身免疫性疾病的自体抗原治疗
- 专利标题: ANTI-T CELL AND AUTOANTIGEN TREATMENT OF AUTOIMMUNE DISEASE
- 专利标题(中): ANTI-T细胞和自身免疫性疾病的自体抗原治疗
-
申请号: EP06701862.2申请日: 2006-02-06
-
公开(公告)号: EP1848806A1公开(公告)日: 2007-10-31
- 发明人: JEVNIKAR, Anthony , MA, Shengwu , AINLEY, William, Michael , MERLO, Donald Joseph , RUSSELL, Sean, Michael , ARMSTRONG, Janna, M.
- 申请人: Dow AgroSciences LLC , Plantigen Inc.
- 申请人地址: 9330 Zionsville Road Indianapolis, Indiana 46268 US
- 专利权人: Dow AgroSciences LLC,Plantigen Inc.
- 当前专利权人: Dow AgroSciences LLC,Plantigen Inc.
- 当前专利权人地址: 9330 Zionsville Road Indianapolis, Indiana 46268 US
- 代理机构: Davies, Jonathan Mark
- 优先权: US649565P 20050204
- 国际公布: WO2006081669 20060810
- 主分类号: C12N15/82
- IPC分类号: C12N15/82 ; C12N15/60 ; C12N15/24 ; A61P3/10 ; A61K31/52 ; A61K31/519 ; A61K39/395 ; A61K39/00 ; A61K38/20 ; A61K38/13
摘要:
The invention is directed to a new method for the treatment of new onset Type I diabetes in mammals or for the treatment of pre-Type I diabetic mammals where the method comprises administering (a) anti-T cell therapy to the mammal and administering (b) an autoantigen and optional mucosal antigen composition, wherein (a) and (b) are administered concurrently or sequentially Exemplified is a treatment using a mixture of anti-CD3 antibodies, a glutamic acid decarboxylase (GAD) autoantigen, and an immunoregulatory cytokine Canme GAD sequences are also disclosed.
信息查询
IPC分类: